The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report ; volume:21 ; number:1 ; day:1 ; month:2 ; year:2021 ; pages:1-6 ; date:12.2021
BMC infectious diseases ; 21, Heft 1 (1.2.2021), 1-6, 12.2021
- Creator
-
Bjørkto, Magnus Holter
Barratt-Due, Andreas
Nordøy, Ingvild
Dörje, Christina
Galteland, Eivind
Lind, Andreas
Hilli, Abdulkarim
Aukrust, Pål
Mjøen, Geir
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-021-05789-2
- URN
-
urn:nbn:de:101:1-2021032521253789453761
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bjørkto, Magnus Holter
- Barratt-Due, Andreas
- Nordøy, Ingvild
- Dörje, Christina
- Galteland, Eivind
- Lind, Andreas
- Hilli, Abdulkarim
- Aukrust, Pål
- Mjøen, Geir
- SpringerLink (Online service)
Other Objects (12)
The use of eculizumab in gemcitabine induced thrombotic microangiopathy
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report
Two cases of carfilzomib‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma
Narsoplimab for severe transplant-associated thrombotic microangiopathy
Thrombotic microangiopathy associated with Valproic acid toxicity
Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer
Nintedanib-Induced Renal Thrombotic Microangiopathy
Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report
The use of eculizumab in gemcitabine induced thrombotic microangiopathy
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report
Two cases of carfilzomib‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma
Narsoplimab for severe transplant-associated thrombotic microangiopathy
Thrombotic microangiopathy associated with Valproic acid toxicity
Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer
Nintedanib-Induced Renal Thrombotic Microangiopathy
Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report
The use of eculizumab in gemcitabine induced thrombotic microangiopathy
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy
Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report
Two cases of carfilzomib‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma
Narsoplimab for severe transplant-associated thrombotic microangiopathy
Thrombotic microangiopathy associated with Valproic acid toxicity
Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer
Nintedanib-Induced Renal Thrombotic Microangiopathy